Results 91 to 100 of about 29,612 (294)

The 'incidentaloma' of the pituitary gland. Is neurosurgery required? [PDF]

, 1990
We describe a series of 18 patients with an intrasellar mass incidentally discovered by computed tomography or magnetic resonance imaging. The average size of the mass was 13 mm, with a range from 5 to 25 mm.
Allolio, Bruno, Menzel, Jürgen, Reincke, Martin, Saeger, Wolfgang, Winkelmann, Werner   +4 more
core   +1 more source

Nonapeptide cell size differs between male morphs of the West African cichlid, Pelvicachromis pulcher

Journal of Fish Biology, EarlyView.
Abstract Alternative male morphs are found in many species of fishes. These morphs often differ in suites of social behaviours, such as aggression and territoriality, associated with alternative reproductive tactics. Such consistent morph‐typical behavioural profiles suggest common differences in underlying neuroendocrine mechanisms.
Adam R. Reddon, Douglas R. Wylie, Peter L. Hurd   +2 more
wiley   +1 more source

Primary Hypothyroidism With Markedly High Prolactin

Frontiers in Endocrinology, 2016
Secondary Pituitary enlargement due to primary hypothyroidism is not a common manifestation. The loss of thyroxin feedback inhibition in primary hypothyroidism causes overproduction of thyroid-releasing hormone (TRH), which results in secondary pituitary
MOHD SALEEM ANSARI, MUSSA H. ALMALKI, MUSSA H. ALMALKI   +2 more
doaj   +1 more source

Potential health benefits of cold‐water immersion: the central role of PGC‐1α

The Journal of Physiology, EarlyView.
Abstract figure legend Cold‐water immersion (CWI) elicits autonomic, somato‐motoric (shivering thermogenesis), endocrine and metabolic, sensory transduction, and local biophysical effects that may converge on the transcriptional co‐activator PGC‐1α (centre).
Erich Hohenauer, Wafa Douzi, Johannes Burtscher   +2 more
wiley   +1 more source

Role of thyrotropin-releasing hormone test in re-evaluation of congenital hypothyroidism

Kaohsiung Journal of Medical Sciences, 2014
The thyrotropin-releasing hormone (TRH) test is useful for differentiating central and primary hypothyroidism, and is also valuable for diagnosing hypothyroidism. The threshold of the TRH test is usually set at 10–40 mIU/L.
Li-Min Chen, Yen-Chun Chen, Hui-Pin Hsiao, Bai-Hsiun Chen, Mei-Chyn Chao   +4 more
doaj   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

Acta Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset, Roy Miodini Nilsen, Kristian Løvås, Kathrine Halsøy, Håkon Reikvam, Ann‐Elin Meling Stokland, Grethe Åstrøm Ueland, Anette S. B. Wolff, Hans Christian D. Aass, Sjur Reppe, Eystein Sverre Husebye, Eyvind Rødahl, Tor Paaske Utheim, Hans Olav Ueland   +13 more
wiley   +1 more source

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

Thyrotropin-releasing hormone in cardiovascular pathophysiology

Regulatory Peptides, 2005
Thyrotropin (TSH)-releasing hormone (TRH) also known as thyroliberin was the first of a number of peptides exerting several roles as a hormone and as a neuropeptide. Its ubiquitous distribution in the hypothalamus and in the extrahypothalamic regions and its diverse pharmacological and physiological effects are all features of its dual functions.
Garcia, Silvia Ines, Pirola, Carlos José   +1 more
openaire   +3 more sources

The challenge of pituitary hyperplasia differential diagnosis in a young girl with growth arrest

Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche
Growth arrest is an alarming condition which requires precise and tempestive investigations in order to provide accurate diagnosis. Long-standing primary hypothyroidism (PHT) may rarely occur as a growth arrest as the only clinical sign at onset in ...
Aurora Lanzafame, Tiziana Abbate, Giuseppina Zirilli, Flavia Caime, Domenico Corica, Malgorzata Wasniewska   +5 more
doaj   +1 more source

Répression transcriptionnelle du gène TRH [PDF]

, 2005
Les hormones thyroïdiennes (HT : T3, T4) exerçant des effets pléiotropes chez les vertébrés, leur synthèse et leur sécrétion doivent être finement contrôlées.
Demeneix, Barbara A., Dupré, Sandrine M., Guissouma, Hajer   +2 more
core   +1 more source